BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 10517509)

  • 1. Alpha-synuclein in Lewy body disease and Alzheimer's disease.
    Hashimoto M; Masliah E
    Brain Pathol; 1999 Oct; 9(4):707-20. PubMed ID: 10517509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases.
    Hashimoto M; Rockenstein E; Crews L; Masliah E
    Neuromolecular Med; 2003; 4(1-2):21-36. PubMed ID: 14528050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of NACP/alpha-synuclein and its role in Alzheimer's disease.
    Iwai A
    Biochim Biophys Acta; 2000 Jul; 1502(1):95-109. PubMed ID: 10899435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.
    Bayer TA; Jäkälä P; Hartmann T; Havas L; McLean C; Culvenor JG; Li QX; Masters CL; Falkai P; Beyreuther K
    Neurosci Lett; 1999 May; 266(3):213-6. PubMed ID: 10465711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies.
    Klucken J; McLean PJ; Gomez-Tortosa E; Ingelsson M; Hyman BT
    Neurochem Res; 2003 Nov; 28(11):1683-91. PubMed ID: 14584822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
    Sierra M; Gelpi E; Martí MJ; Compta Y
    Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-synuclein inclusions in Alzheimer and Lewy body diseases.
    Mukaetova-Ladinska EB; Hurt J; Jakes R; Xuereb J; Honer WG; Wischik CM
    J Neuropathol Exp Neurol; 2000 May; 59(5):408-17. PubMed ID: 10888371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein, Abeta and Alzheimer's disease.
    Wirths O; Bayer TA
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):103-8. PubMed ID: 12551731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression.
    Sorrentino ZA; Goodwin MS; Riffe CJ; Dhillon JS; Xia Y; Gorion KM; Vijayaraghavan N; McFarland KN; Golbe LI; Yachnis AT; Giasson BI
    Acta Neuropathol Commun; 2019 Sep; 7(1):142. PubMed ID: 31477175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewy body pathology in Alzheimer's disease.
    Kotzbauer PT; Trojanowsk JQ; Lee VM
    J Mol Neurosci; 2001 Oct; 17(2):225-32. PubMed ID: 11816795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence of pathology in dementia with Lewy bodies and Alzheimer's disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease.
    Winslow AR; Moussaud S; Zhu L; Post KL; Dickson DW; Berezovska O; McLean PJ
    Brain; 2014 Jul; 137(Pt 7):1958-70. PubMed ID: 24860142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.
    Campbell BC; Li QX; Culvenor JG; Jäkälä P; Cappai R; Beyreuther K; Masters CL; McLean CA
    Neurobiol Dis; 2000 Jun; 7(3):192-200. PubMed ID: 10860784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
    Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
    Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
    Galvin JE; Uryu K; Lee VM; Trojanowski JQ
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13450-5. PubMed ID: 10557341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein: its biological function and role in neurodegenerative diseases.
    Kaplan B; Ratner V; Haas E
    J Mol Neurosci; 2003 Apr; 20(2):83-92. PubMed ID: 12794302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.
    Arai Y; Yamazaki M; Mori O; Muramatsu H; Asano G; Katayama Y
    Brain Res; 2001 Jan; 888(2):287-296. PubMed ID: 11150486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease.
    Overk CR; Masliah E
    Biochem Pharmacol; 2014 Apr; 88(4):508-16. PubMed ID: 24462903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.